Status:

WITHDRAWN

Stereotactic Ablative Radiotherapy (SAbR) for Treatment of Ventricular Tachycardia (VT) Refractory Standard Invasive Ablation Techniques

Lead Sponsor:

University of Texas Southwestern Medical Center

Conditions:

Tachycardia, Ventricular

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the clinical efficacy and safety of stereotactic ablative radiotherapy (SAbR), also known as stereotactic body radiation therapy (SBRT), for treatment of ventr...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Have an ICD implanted \> 6 months and all VT episodes in the past 6 months are available in device memory.
  • Within the past 3 months, the patient has at least one episode of symptomatic monomorphic VT that requires ICD treatment (anti-tachycardia pacing and/or ICD shock) or was sustained/incessant but falls under ICD treatment zone. These VT episodes must occur after at least one standard invasive VT ablation or occur in a patient that is clinically deemed not eligible to the standard VT ablation procedure.
  • Two independent cardiac electrophysiologists reviewed the case and agreed that the patient would benefit from suppression of these VT episodes but there is no optimal invasive VT ablation or antiarrhythmic drug options.

Exclusion

  • Has contraindication to receive SAbR or VT clinically deemed not suitable for SAbR.
  • Is pregnant
  • Has severe co-morbid medical condition or terminal illness and is unlikely to survive more than 6 months regardless of VT status based on clinical judgement by treating or enrolling physicians.
  • On potent immunosuppressive therapy (e.g., post organ transplant)
  • Has severe collagen vascular disorder with organ involvement
  • Not willing or not able to consent to participate in the study

Key Trial Info

Start Date :

February 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2025

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04334811

Start Date

February 1 2023

End Date

March 1 2025

Last Update

August 17 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas Southwestern Medical Center - Dallas

Dallas, Texas, United States, 75390